Stock listing
Corbus Pharmaceuticals Holdings, Inc.
Selected listing: 3371 · FWB · EUR · DE
Corbus Pharmaceuticals Holdings, Inc. (Frankfurt:3371), Health Technology. Latest release Sep 29, 2026: Corbus Pharmaceuticals Announces First Patient Dosed…
- Ticker
- Frankfurt:3371
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Frankfurt
- Currency
- EUR
About Corbus Pharmaceuticals Holdings, Inc.
The company focuses on developing innovative therapies for rare and serious diseases. Corbus is committed to advancing its clinical programs and expanding its portfolio to address unmet medical needs.
Latest news from Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer
September 28, 2026
Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
September 14, 2026
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
September 11, 2026
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 17, 2026
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
August 6, 2026
Events
Replays
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q3 2020 Earnings Call
Tue, Nov 10, 2020 · 08:30 AM ET
WatchCorbus Pharmaceuticals Holdings, Inc. (CRBP) Q2 2020 Earnings Call
Thu, Aug 06, 2020 · 08:30 AM ET
WatchCorbus Pharmaceuticals Holdings, Inc. (CRBP) Q1 2020 Earnings Call
Mon, May 11, 2020 · 08:30 AM ET
Watch
Research Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. company profile
View the public company page for Corbus Pharmaceuticals Holdings, Inc. on 6ix.
Corbus Pharmaceuticals Holdings, Inc. news
Read company news and market updates connected to Corbus Pharmaceuticals Holdings, Inc..
Corbus Pharmaceuticals Holdings, Inc. investor events
Find investor webinars, events, and replay context for Corbus Pharmaceuticals Holdings, Inc..
Alternate listings
CRBP:NASDAQ
US · USD
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
A3D54P:LS
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
3371:GETTEX
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
A3D54P:LSX
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
CRBP:BOATS
US · USD
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
0SZI:LSE
GB · USD
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
3371:TRADEGATE
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
3371:DUS
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
3371:HAM
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
3371:MUN
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.
3371:SWB
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:FWB.